Short Name-A*ST大药
Symbol-A603963
Company NameDali Pharmaceutical Co.,Ltd
Listing DateSep 22, 2017
Issue Price12.58
Shares Offered25.00M share(s)
FoundedMar 22, 2004
Listed ExchangeSH Stock Exchange
Legal Representativecuixiandai yin
General Managerpeirongdai wu
Secretarypeirong wu
Accounting FirmShinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
Securities Representativeliyao xu
Legal CounselShanghai Tongli Law Firm
Employees265
Phone0872-8880055
Office Address118 Huancheng West Road, Xiaguan, Dali City, Yunnan Province
Zip Code671000
Registered AddressNo. 118, Huancheng West Road, Xiaguan, Dali City, Dali Bai Autonomous Prefecture, Yunnan Province
Fax0872-8880055
Emaildongban@daliyaoye.cn
Business License532900400008869
BusinessLicense items: pharmaceutical production; pharmaceutical wholesale; pharmaceutical retail; drug contract production; pharmaceutical import and export; cosmetics production; health products and disposable medical products production; health food production; food production; food sales; Class II medical device production; Class III medical device production; Class III medical device management (projects subject to approval according to law, business activities can only be carried out after approval by relevant departments. Specific business projects are subject to approval documents or licenses from relevant departments) General projects: wholesale of cosmetics; retail of cosmetics; retail of cosmetics; sales of hygiene products and disposable medical products; health care Food (pre-packaged) sales; Class I medical device production; Class I medical device sales; Class II medical device sales; daily mask (non-medical) production; daily mask (non-medical) sales; labor protection supplies sales; medical packaging materials manufacturing; packaging materials and products sales; non-residential real estate leasing (except for projects subject to approval by law, independent business activities carried out by law with a business license). (with the exception of those involving the implementation of special access management measures by the country)